{"id":"W2147791981","doi":"10.1136/annrheumdis-2012-201766","title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":532,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Cilag; Procter and Gamble; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories","keywords":"Adalimumab; Medicine; BASDAI; Ankylosing spondylitis; Placebo; Internal medicine; Spondylitis; Clinical endpoint; Visual analogue scale; Physical therapy; Randomized controlled trial; Arthritis; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003128958,0.001729001,0.003990112,0.0005340424,0.0005016821,0.001579915,0.001256743,0.002574403,0.008294814],"category_scores_gemma":[0.00329439,0.0007615587,0.00231418,0.0004604057,0.001330207,0.001323935,0.0004996207,0.002482982,0.001259527],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000663698,"about_ca_system_score_gemma":0.000863619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004583623,"about_ca_topic_score_gemma":0.0008810436,"domain_scores_codex":[0.9983122,0.001022675,0.000159647,0.0002397836,0.0001124359,0.0001532883],"domain_scores_gemma":[0.9980389,0.0006654877,0.0005501862,0.0001630914,0.0001326805,0.000449692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836924,0.004074347,0.0003869608,0.0006719551,0.0005336162,0.00002380798,0.00003065425,0.00007298686,0.001336878,0.00002468641,0.0002328534,0.00891889],"study_design_scores_gemma":[0.9429373,0.05470816,0.00153523,0.00003348163,0.0002538695,0.00002368265,0.00001091916,0.00008369733,0.0001509667,0.00002668673,0.0002277663,0.000008295548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808658,0.0130735,0.0004177054,0.0006517311,0.0006429353,0.002092011,0.0007894073,0.0001164567,0.001350341],"genre_scores_gemma":[0.9851549,0.004558501,0.001222227,0.001025877,0.001202982,0.00359326,0.001053297,0.00002707071,0.002161919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008294814,"threshold_uncertainty_score":0.02774894,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01293949533890286,"score_gpt":0.2608029505348781,"score_spread":0.2478634551959752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}